Antagonistic pathogenic pleiotropy and PF4 longevity research
exploratoryExplore whether pathological states without expected mortality increases can reveal protective factors for chronic disease, using elevated platelet factor 4 in essential thrombocythemia as an example.
Hypothesis-driven biomedical research based on literature and disease observation; proposes PF4 as a candidate factor linked to reduced age-associated immune and cognitive decline in mice and possible treatment relevance for age-associated illness.
2024 Rejuvenation Research publication describing the antagonistic pathogenic pleiotropy concept using PF4 and essential thrombocythemia.
The publication hypothesizes that elevated PF4 may offset morbidity from hematologic pathology and could help identify protective factors for chronic disease, but no company development milestone is stated.